These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1659174

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 23. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
    Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Saijo N.
    Eur J Cancer; 1991; 27(5):571-5. PubMed ID: 1647183
    [Abstract] [Full Text] [Related]

  • 24. Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
    Jelić S, Mitrović L, Radosavljević D, Elezar E, Babović N, Kovcin V, Tomasević Z, Kovacević S, Gavrilović D, Radulović S.
    Lung Cancer; 2001 Oct; 34(1):1-13. PubMed ID: 11557107
    [Abstract] [Full Text] [Related]

  • 25. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P, Becker H, Bülzebruck H, Djawid N, Ruchalla E, Stiefel P, Tessen HW.
    Onkologie; 1988 Oct; 11 Suppl 2():47-56. PubMed ID: 2851761
    [Abstract] [Full Text] [Related]

  • 26. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
    Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O.
    Lung Cancer; 1994 Dec; 11(5-6):373-84. PubMed ID: 7704494
    [Abstract] [Full Text] [Related]

  • 27. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
    Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M.
    J Clin Oncol; 2010 Jul 10; 28(20):3299-306. PubMed ID: 20530281
    [Abstract] [Full Text] [Related]

  • 28. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb 10; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

  • 29. Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer.
    Kubota K, Furuse K, Kawahara M, Kodama N, Ogawara M, Takada M, Masuda N, Negoro S, Matsui K, Takifuji N, Kudoh S, Kusunoki Y, Fukuoka M.
    Cancer Chemother Pharmacol; 1997 Feb 10; 40(6):469-74. PubMed ID: 9332460
    [Abstract] [Full Text] [Related]

  • 30. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
    Itami S, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N, Nakagawa K.
    Gan To Kagaku Ryoho; 1990 May 10; 17(5):1015-20. PubMed ID: 2159265
    [Abstract] [Full Text] [Related]

  • 31. Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
    Gridelli C, Pepe R, Palmeri S, Iacobelli S, Gentile M, Gebbia V, Garufi C, Airoma G, Palmieri G, Russo A.
    Cancer Chemother Pharmacol; 1991 May 10; 28(5):405-7. PubMed ID: 1655301
    [Abstract] [Full Text] [Related]

  • 32. Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
    Cullen MH, Joshi R, Chetiyawardana AD, Woodroffe CM.
    Br J Cancer; 1988 Sep 10; 58(3):359-61. PubMed ID: 2846024
    [Abstract] [Full Text] [Related]

  • 33. A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.
    Ali MA, Kraut MJ, Valdivieso M, Wozniak AJ, Cummings G, Kalemkerian GP.
    Cancer Invest; 2000 Sep 10; 18(1):1-5. PubMed ID: 10701360
    [Abstract] [Full Text] [Related]

  • 34. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
    Vansteenkiste JF, De Leyn PR, Deneffe GJ, Lievens YN, Nackaerts KL, Van Raemdonck DE, van der Schueren E, Lerut TE, Demedts MG.
    Ann Oncol; 1998 Mar 10; 9(3):261-7. PubMed ID: 9602259
    [Abstract] [Full Text] [Related]

  • 35. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E, Paul K.
    Semin Oncol; 1992 Feb 10; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [Abstract] [Full Text] [Related]

  • 36. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
    Zhang X, Sun Y, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1999 May 10; 21(3):220-3. PubMed ID: 11776842
    [Abstract] [Full Text] [Related]

  • 37. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
    Dhingra HM, Valdivieso M, Carr DT, Chiuten DF, Farha P, Murphy WK, Spitzer G, Umsawasdi T.
    J Clin Oncol; 1985 Feb 10; 3(2):176-83. PubMed ID: 2981982
    [Abstract] [Full Text] [Related]

  • 38. [Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
    Nakabayashi T, Miyamoto H, Fujikane T, Shimizu T, Yasuda S, Akita H, Sakai E, Onodera S, Ohsaki Y, Kawakami Y.
    Gan To Kagaku Ryoho; 1992 Jan 10; 19(1):61-7. PubMed ID: 1309633
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.
    Fukuoka M, Negoro S, Masuda N, Kusunoki Y, Matsui K, Ryu S, Takifuji N, Kudoh S, Takada M.
    Am J Clin Oncol; 1992 Feb 10; 15(1):18-22. PubMed ID: 1312768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.